インフルエンザ診断検査市場：検査タイプ別、最終用途別、予測、2023年～2032年

インフルエンザ診断検査市場は、2023年から2032年にかけて6.3%のCAGRを記録すると推定されます。

これは、正確かつ迅速な診断ソリューションの重要な必要性を浮き彫りにするインフルエンザの世界的流行が繰り返されているためです。WHOの2023年10月の報告書によると、季節性インフルエンザの年間患者数は約10億人で、その中には300万～500万人の重症患者も含まれています。世界がインフルエンザの脅威と闘う中、診断検査は早期発見、効果的な治療、ウイルスの封じ込めに役立っています。

分子アッセイ、迅速抗原検査、核酸増幅技術を含む診断ツールの絶え間ない進化は、インフルエンザ診断の精度と効率を高めています。より高感度で、特異的で、迅速な診断法の追求は、研究開発投資を促しています。

インフルエンザ診断検査産業は、検査タイプ、最終用途、地域によって区分されます。

ポリメラーゼ連鎖反応（PCR）および核酸増幅検査は、インフルエンザウイルスの検出において高い感度と特異性を提供するため、分子診断アッセイ分野は予測期間中に大きく成長する見込みです。この精度は、正確でタイムリーな診断のために重要であり、適切な治療と封じ込め対策を迅速に開始することを可能にします。迅速で信頼性の高い診断ソリューションに対する需要の高まりと、分子診断技術の進歩が、同分野の成長に寄与しています。

調査研究部門は、診断技術や診断手法の進歩に重要な役割を果たすため、2023-2032年の間に市場で注目すべき収益を上げると思われます。研究室は、革新的な診断アッセイの開発や既存の検査プラットフォームの継続的な改良に貢献しています。調査ラボにおける優れた診断精度の追求は、より信頼性が高く効率的な検査の提供に直結し、診断能力の全体的な水準を向上させる。

アジア太平洋地域のインフルエンザ診断検査業界は、急速な都市化、ヘルスケア意識の向上、感染症対策に対する政府の積極的な取り組みなどを背景に、2032年まで大きな成長率を示すと予測されています。インフルエンザの罹患率の増加と感染症が経済的に与える影響に対する意識の高まりが、精密な診断ソリューションに対する需要を促進しています。さらに、ヘルスケア機関、政府、診断企業間の戦略的協力関係が、インフルエンザ発生への効率的な対応に寄与しており、この地域の市場展望に好影響を与えています。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 インフルエンザ診断検査業界洞察

• エコシステム分析
• 業界への影響要因
  • 促進要因
    • インフルエンザの流行拡大
    • 迅速診断検査に対する需要の高まり
    • 技術の進歩
    • 研究開発活動の増加
  • 業界の潜在的リスク＆課題
    • 検査感度と特異度のばらつき
    • 厳しい規制ガイドライン
• 成長可能性分析
• COVID-19影響分析
• 規制状況
• 償還シナリオ
• 技術展望
• GAP分析
• ポーター分析
• PESTEL分析

第4章 競合情勢

• イントロダクション
• 企業マトリックス分析
• 企業シェア分析
• 競合ポジショニングマトリックス
• ベンダー・マトリックス分析
• 戦略ダッシュボード

第5章 インフルエンザ診断検査の市場規模推移と予測：検査タイプ別

• 主要検査タイプの動向
• 従来型診断検査
  • 迅速インフルエンザ診断検査（RIDT）
  • 直接蛍光抗体検査（DFAT）
  • ウイルス培養
  • 血清学的検査
• 分子診断検査
  • RT-PCR
  • ループ媒介等温増幅法（LAMP）
  • 核酸配列に基づく増幅検査（NASBAT）
  • 簡易増幅法（SAMBA）
  • その他の分子診断アッセイ

第6章 インフルエンザ診断検査市場規模・予測：最終用途別

• 主要エンドユーザー動向
• 病院
• 診断センター
• 調査研究所
• その他のエンドユーザー

第7章 インフルエンザ診断検査市場規模・予測：地域別

• 主要地域動向
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • その他ラテンアメリカ
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • その他のMEA

第8章 企業プロファイル

• F. Hoffmann-La Roche Ltd
• Abbott
• Becton, Dickinson and Company
• Coris BioConcept
• DiaSorin SpA
• Meridian Bioscience Inc.
• Quidel Corporation
• Sekisui Diagnostics
• Thermo Fischer Scientific Inc.
• Hologic Inc.

Data Tables

• TABLE 1. Product mapping
• TABLE 2. Market revenue, by test type (2022)
• TABLE 3. Market revenue, by end-use (2022)
• TABLE 4. Market share, by region (2022)
• TABLE 5. Competitive positioning matrix
• TABLE 6. Vendor matrix analysis
• TABLE 7. Traditional diagnostic test market size, 2018 - 2024 (USD Million)
• TABLE 8. Traditional diagnostic test market size, 2025 - 2032 (USD Million)
• TABLE 9. Rapid influenza diagnostic test (RIDT) market size, 2018 - 2024 (USD Million)
• TABLE 10. Rapid influenza diagnostic test (RIDT) market size, 2025 - 2032 (USD Million)
• TABLE 11. Direct fluorescent antibody test (DFAT) market size, 2018 - 2024 (USD Million)
• TABLE 12. Direct fluorescent antibody test (DFAT) market size, 2025 - 2032 (USD Million)
• TABLE 13. Viral culture market size, 2018 - 2024 (USD Million)
• TABLE 14. Viral culture market size, 2025 - 2032 (USD Million)
• TABLE 15. Hospital market size, 2018 - 2024 (USD Million)
• TABLE 16. Hospital market size, 2025 - 2032 (USD Million)
• TABLE 17. Assisted living market size, 2018 - 2024 (USD Million)
• TABLE 18. Assisted living market size, 2025 - 2032 (USD Million)
• TABLE 19. Serological assay market size, 2018 - 2024 (USD Million)
• TABLE 20. Serological assay market size, 2025 - 2032 (USD Million)
• TABLE 21. Molecular diagnostic assay market size, 2018 - 2024 (USD Million)
• TABLE 22. Molecular diagnostic assay market size, 2025 - 2032 (USD Million)
• TABLE 23. RT-PCR market size, 2018 - 2024 (USD Million)
• TABLE 24. RT-PCR market size, 2025 - 2032 (USD Million)
• TABLE 25. Loop-mediated isothermal amplification-based assay (LAMP) market size, 2018 - 2024 (USD Million)
• TABLE 26. Loop-mediated isothermal amplification-based assay (LAMP) market size, 2025 - 2032 (USD Million)
• TABLE 27. Nucleic acid sequence-based amplification test (NASBAT) market size, 2018 - 2024 (USD Million)
• TABLE 28. Nucleic acid sequence-based amplification test (NASBAT) market size, 2025 - 2032 (USD Million)
• TABLE 29. Simple amplification-based Assay (SAMBA) years market size, 2018 - 2024 (USD Million)
• TABLE 30. Simple amplification-based Assay (SAMBA) years market size, 2025 - 2032 (USD Million)
• TABLE 31. Other molecular diagnostic assays market size, 2018 - 2024 (USD Million)
• TABLE 32. Other molecular diagnostic assays market size, 2025 - 2032 (USD Million)
• TABLE 33. Hospitals years market size, 2018 - 2024 (USD Million)
• TABLE 34. Hospitals years market size, 2025 - 2032 (USD Million)
• TABLE 35. Diagnostics centers market size, 2018 - 2024 (USD Million)
• TABLE 36. Diagnostics centers market size, 2025 - 2032 (USD Million)
• TABLE 37. Research laboratories market size, 2018 - 2024 (USD Million)
• TABLE 38. Research laboratories market size, 2025 - 2032 (USD Million)
• TABLE 39. Other end-users market size, 2018 - 2024 (USD Million)
• TABLE 40. Other end-users market size, 2025 - 2032 (USD Million)
• TABLE 41. North America influenza diagnostic tests market size, by country, 2018 - 2024, (USD Million)
• TABLE 42. North America influenza diagnostic tests market size, by country, 2025 - 2032, (USD Million)
• TABLE 43. North America influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 44. North America influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 45. North America influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 46. North America influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 47. North America influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 48. North America influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 49. North America influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 50. North America influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 51. U.S. influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 52. U.S. influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 53. U.S. influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 54. U.S. influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 55. U.S. influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 56. U.S. influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 57. U.S. influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 58. U.S. influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 59. U.S. influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 60. U.S. influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 61. Canada influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 62. Canada influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 63. Canada influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 64. Canada influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 65. Canada influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 66. Canada influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 67. Canada influenza diagnostic tests market size, by payment source, 2018 - 2024, (USD Million)
• TABLE 68. Canada influenza diagnostic tests market size, by payment source, 2025 - 2032, (USD Million)
• TABLE 69. Canada influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 70. Canada influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 71. Europe influenza diagnostic tests market size, by country, 2018 - 2024, (USD Million)
• TABLE 72. Europe influenza diagnostic tests market size, by country, 2025 - 2032, (USD Million)
• TABLE 73. Europe influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 74. Europe influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 75. Europe influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 76. Europe influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 77. Europe influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 78. Europe influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 79. Europe influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 80. Europe influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 81. Germany influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 82. Germany influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 83. Germany influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 84. Germany influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 85. Germany influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 86. Germany influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 87. Germany influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 88. Germany influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 89. UK influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 90. UK influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 91. UK influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 92. UK influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 93. UK influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 94. UK influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 95. UK influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 96. UK influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 97. France influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 98. France influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 99. France influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 100. France influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 101. France influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 102. France influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 103. France influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 104. France influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 105. Spain influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 106. Spain influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 107. Spain influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 108. Spain influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 109. Spain influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 110. Spain influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 111. Spain influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 112. Spain influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 113. Italy influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 114. Italy influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 115. Italy influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 116. Italy influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 117. Italy influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 118. Italy influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 119. Italy influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 120. Italy influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 121. Rest of Europe influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 122. Rest of Europe influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 123. Rest of Europe influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 124. Rest of Europe influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 125. Rest of Europe influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 126. Rest of Europe influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 127. Rest of Europe influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 128. Rest of Europe influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 129. Asia Pacific influenza diagnostic tests market size, by country, 2018 - 2024, (USD Million)
• TABLE 130. Asia Pacific influenza diagnostic tests market size, by country, 2025 - 2032, (USD Million)
• TABLE 131. Asia Pacific influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 132. Asia Pacific influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 133. Asia Pacific influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 134. Asia Pacific influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 135. Asia Pacific influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 136. Asia Pacific influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 137. Asia Pacific influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 138. Asia Pacific influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 139. China influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 140. China influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 141. China influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 142. China influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 143. China influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 144. China influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 145. China influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 146. China influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 147. Japan influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 148. Japan influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 149. Japan influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 150. Japan influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 151. Japan influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 152. Japan influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 153. Japan influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 154. Japan influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 155. India influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 156. India influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 157. India influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 158. India influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 159. India influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 160. India influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 161. India influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 162. India influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 163. Australia influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 164. Australia influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 165. Australia influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 166. Australia influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 167. Australia influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 168. Australia influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 169. Australia influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 170. Australia influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 171. South Korea influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 172. South Korea influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 173. South Korea influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 174. South Korea influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 175. South Korea influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 176. South Korea influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 177. South Korea influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 178. South Korea influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 179. Rest of Asia Pacific influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 180. Rest of Asia Pacific influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 181. Rest of Asia Pacific influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 182. Rest of Asia Pacific influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 183. Rest of Asia Pacific influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 184. Rest of Asia Pacific influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 185. Rest of Asia Pacific influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 186. Rest of Asia Pacific influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 187. Latin America influenza diagnostic tests market size, by country, 2018 - 2024, (USD Million)
• TABLE 188. Latin America influenza diagnostic tests market size, by country, 2025 - 2032, (USD Million)
• TABLE 189. Latin America influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 190. Latin America influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 191. Latin America influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 192. Latin America influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 193. Latin America influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 194. Latin America influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 195. Latin America influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 196. Latin America influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 197. Brazil influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 198. Brazil influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 199. Brazil influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 200. Brazil influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 201. Brazil influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 202. Brazil influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 203. Brazil influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 204. Brazil influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 205. Mexico influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 206. Mexico influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 207. Mexico influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 208. Mexico influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 209. Mexico influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 210. Mexico influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 211. Mexico influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 212. Mexico influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 213. Argentina influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 214. Argentina influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 215. Argentina influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 216. Argentina influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 217. Argentina influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 218. Argentina influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 219. Argentina influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 220. Argentina influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 221. Rest of Latin America influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 222. Rest of Latin America influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 223. Rest of Latin America influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 224. Rest of Latin America influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 225. Rest of Latin America influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 226. Rest of Latin America influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 227. Rest of Latin America influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 228. Rest of Latin America influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 229. MEA influenza diagnostic tests market size, by country, 2018 - 2024, (USD Million)
• TABLE 230. MEA influenza diagnostic tests market size, by country, 2025 - 2032, (USD Million)
• TABLE 231. MEA influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 232. MEA influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 233. MEA influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 234. MEA influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 235. MEA influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 236. MEA influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 237. MEA influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 238. MEA influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 239. South Africa influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 240. South Africa influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 241. South Africa influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 242. South Africa influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 243. South Africa influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 244. South Africa influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 245. South Africa influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 246. South Africa influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 247. Saudi Arabia influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 248. Saudi Arabia influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 249. Saudi Arabia influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 250. Saudi Arabia influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 251. Saudi Arabia influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 252. Saudi Arabia influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 253. Saudi Arabia influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 254. Saudi Arabia influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 255. Saudi Arabia influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 256. Saudi Arabia influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 257. UAE influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 258. UAE influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 259. UAE influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 260. UAE influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 261. UAE influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 262. UAE influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 263. UAE influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 264. UAE influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
• TABLE 265. Rest of MEA influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
• TABLE 266. Rest of MEA influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
• TABLE 267. Rest of MEA influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
• TABLE 268. Rest of MEA influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
• TABLE 269. Rest of MEA influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
• TABLE 270. Rest of MEA influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
• TABLE 271. Rest of MEA influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
• TABLE 272. Rest of MEA influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)

Charts & Figures

• FIG. 1 GMI report coverage: Critical research elements
• FIG. 2 Industry segmentation
• FIG. 3 Top-down approach
• FIG. 4 Market estimation and forecast methodology
• FIG. 5 Market forecasting methodology
• FIG. 6 Breakdown of primary participants
• FIG. 7 Influenza diagnostic tests industry 360 degree synopsis, 2018 - 2032
• FIG. 8 Industry ecosystem analysis
• FIG. 9 Industry impact forces
• FIG. 10 Growth potential analysis, by test type
• FIG. 11 Growth potential analysis, by end-use
• FIG. 12 GAP analysis
• FIG. 13 Porter's analysis
• FIG. 14 PESTEL analysis
• FIG. 15 Company matrix analysis, 2022
• FIG. 16 Global company market share analysis, 2022
• FIG. 17 Competitive positioning matrix
• FIG. 18 Strategy dashboard, 2022

Influenza Diagnostic Tests Market is estimated to witness 6.3% CAGR between 2023 and 2032, owing to the recurrent global outbreaks of influenza that highlight the critical need for accurate and rapid diagnostic solutions. As per WHO October 2023 report, there were approximately a billion cases of seasonal influenza annually, which included 3-5 million cases of severe illness. As the world grapples with the ongoing threat of influenza, diagnostic tests help in early detection, effective treatment, and containment of the virus.

The continual evolution of diagnostic tools, including molecular assays, rapid antigen tests, and nucleic acid amplification techniques, enhances the precision and efficiency of influenza diagnosis. The quest for more sensitive, specific, and quicker diagnostic methods encourages R&D investments.

Influenza diagnostic tests industry is segmented on the basis of test type, end-use, and region.

Molecular diagnostic assays segment is poised for substantial growth over the forecast period, as polymerase chain reaction (PCR) and nucleic acid amplification tests, offer high sensitivity and specificity in detecting influenza viruses. This precision is important for accurate and timely diagnosis, allowing for prompt initiation of appropriate treatments and containment measures. The growing demand for rapid and reliable diagnostic solutions, coupled with advancements in molecular diagnostic technologies, contribute to the segment growth.

Research laboratories segment will generate notable revenues for the market during 2023-2032, owing to the instrumental role in advancing diagnostic technologies and methodologies. Research laboratories help in the development of innovative diagnostic assays and the continual improvement of existing testing platforms. The pursuit of excellence in diagnostic accuracy within research laboratories directly translates into the availability of more reliable and efficient tests, elevating the overall standard of diagnostic capabilities.

Asia Pacific influenza diagnostic tests industry is slated to witness a significant growth rate through 2032, attributed to rapid urbanization, increased healthcare awareness, and proactive government initiatives to combat infectious disease. The increasing incidence of influenza, coupled with a rising awareness of the economic impact of infectious diseases, fuels the demand for precise diagnostic solutions. Moreover, strategic collaborations between healthcare institutions, governments, and diagnostic companies contribute to a more efficient response to influenza outbreaks, favoring the regional market outlook.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & working
  • 1.2.1 Data collection
• 1.3 Forecast parameters
• 1.4 COVID-19 impact at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Influenza diagnostic tests industry 360 degree synopsis, 2018 - 2032
• 2.2 Business trends
• 2.3 Regional trends
• 2.4 Test type trend
• 2.5 End-use trends

Chapter 3 Influenza Diagnostic Tests Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of influenza
    • 3.2.1.2 Rise in demand for rapid diagnostic tests
    • 3.2.1.3 Technological advancements
    • 3.2.1.4 Increase in R&D activities
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Variabilities in test sensitivity and specificity
    • 3.2.2.2 Stringent regulatory guidelines
• 3.3 Growth potential analysis
  • 3.3.1 By test type
  • 3.3.2 By end-use
• 3.4 COVID-19 impact analysis
• 3.5 Regulatory landscape
• 3.6 Reimbursement scenario
• 3.7 Technology landscape
• 3.8 GAP analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Company market share analysis, 2022
• 4.4 Competitive positioning matrix
• 4.5 Vendor matrix analysis
• 4.6 Strategy dashboard, 2022

Chapter 5 Influenza Diagnostic Tests Market Size and Forecast, By Test Type (USD Million)

• 5.1 Key test type trends
• 5.2 Traditional diagnostic test
  • 5.2.1 Rapid influenza diagnostic test (RIDT)
  • 5.2.2 Direct fluorescent antibody test (DFAT)
  • 5.2.3 Viral culture
  • 5.2.4 Serological assay
• 5.3 Molecular diagnostic assay
  • 5.3.1 RT-PCR
  • 5.3.2 Loop-mediated isothermal amplification-based Assay (LAMP)
  • 5.3.3 Nucleic acid sequence-based amplification test (NASBAT)
  • 5.3.4 Simple amplification-based assay (SAMBA)
  • 5.3.5 Other molecular diagnostic assays

Chapter 6 Influenza Diagnostic Tests Market Size and Forecast, By End-use (USD Million)

• 6.1 Key end-use trends
• 6.2 Hospitals
• 6.3 Diagnostics centers
• 6.4 Research laboratories
• 6.5 Other end-users

Chapter 7 Influenza Diagnostic Tests Market Size and Forecast, By Region (USD Million)

• 7.1 Key regional trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
  • 7.4.6 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
  • 7.5.4 Rest of Latin America
• 7.6 Middle East & Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE
  • 7.6.4 Rest of MEA

Chapter 8 Company Profiles

• 8.1 F. Hoffmann-La Roche Ltd
• 8.2 Abbott
• 8.3 Becton, Dickinson and Company
• 8.4 Coris BioConcept
• 8.5 DiaSorin SpA
• 8.6 Meridian Bioscience Inc.
• 8.7 Quidel Corporation
• 8.8 Sekisui Diagnostics
• 8.9 Thermo Fischer Scientific Inc.
• 8.10 Hologic Inc.